IceCure Medical Ltd. Stock: price and insider trades · United States

IceCure Medical Ltd., founded in 2006, is a Health Care company based in Caesarea, Israel. Its directors and officers file their transactions with SEC (Form 4). Over the twelve months to 3 November 2026, 7 filings were filed, from 7 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

With 7 filings in twelve months, the company is quieter than the median of 24 filings across the 3,175 companies we follow on the same exchange. On the fundamentals side, the SEC filing (20-F) for the period ending 31 December 2025 lists revenue at 3.4 m USD and net income at -15.1 m USD.

Insider buying of IceCure Medical Ltd. has been absent for the past year. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.